Spevigo 50222-0360
Generic: Spesolimab
Product NDC
50222-0360- Manufacturer
- Leo Pharma Inc.
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- March 9, 2026
- Listing Expires
- December 31, 2027
- Application
- BLA761244
Need to source Spevigo? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Spesolimab | 60 mg/mL |
Drug Class
Interleukin-36 Receptor Antagonist [EPC]Interleukin-36 Receptor Antagonist [EPC]Interleukin-36 Receptor Antagonists [MoA]
Packaging Options(1)
2 VIAL, GLASS in 1 CARTON (50222-360-72) / 7.5 mL in 1 VIAL, GLASS